A new generation of a unique immunoblot test for effective multiplex diagnostics.
Microtiter plate technology paves the way for automation and high throughput of testing. The combination of a reader and advanced software provides comprehensive results and the possibility of connecting to a laboratory information system.
Serological diagnostics is at the heart of laboratory medicine. Our goal is to combine knowledge in immunodiagnostics with the most accurate new technologies and emerging trends, such as automation, saving time and resources. The result is Microblot array, multiplex diagnosis of infectious and autoimmune diseases.
Highly specific recombinant antigens are applied in the form of spots in triplet to a nitrocellulose membrane in the well of a microtiter plate. If specific antibodies are present in the sample, they will bind to the appropriate antigens. The complex is then labelled with the conjugate and detected by colour reaction with the substrate. Each well contains control spots to verify the functionality of the assay and then spots to control the conjugate. The wells also contain calibration spots for quantitative evaluation of the results. Intuitive and user-friendly software is used for semi-quantitative (IP; AU) and quantitative (U/ml) test evaluation. MBA allows the analysis of up to 96 patients per microtiter plate. The platform allows parallel detection of several markers simultaneously, which brings time and money savings. In addition, there is the possibility of automatic processing of kits on open ELISA analysers. Our fast and high quality MBA reader is able to scan and evaluate the entire microtiter plate within 5 minutes. For high user comfort, the components are prepared in working dilution, the same work procedure is used within different kits, and we also provide remote technical support.
We bring a comprehensive sequencing solution using the NGS method, designed with maximum efficiency and ease of use in mind.
User-friendly and intuitive software, diagnostic panels for DNA, RNA analysis, fast service and the perfect know-how of our application specialists - a revolution in the speed of laboratory diagnostics and the availability of personalized medicine.
microRNAs represent the most progressive group of diagnostic and prognostic biomarkers.
A wide range of expression panels and targeted measurements for individual miRNAs on the principle of immunoblot or qPCR opens up new possibilities for the diagnosis of serious pathologies. Where traditional tests end, miRNA begins.
Fully automated CLIA solution.
An attractive portfolio of innovative and established diagnostic parameters combined with a state-of-the-art CLIA analyzer forms a comprehensive, fully automated system for any diagnostic laboratory. Versatile, fast, smooth, intuitive - this is the CLIA solution by BioVendor Group.